Primary versus secondary antiemetic prophylaxis with NK1 receptor antagonists in patients affected by gastrointestinal malignancies and treated with a doublet or triplet combination regimen including oxaliplatin and/or irinotecan plus fluoropyrimidines: A propensity score matched analysis

AIM: The aim of the current study is to investigate the impact of primary compared to secondary chemotherapy-induced nausea and vomiting (CINV) prophylaxis with NK1 receptor antagonists (NK1-RA) in patients affected by gastrointestinal malignancies and treated with oxaliplatin- and/or irinotecan-bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Parisi, Alessandro, Giampieri, Riccardo, Mammarella, Alex, Felicetti, Cristiano, Salvatore, Lisa, Bensi, Maria, Maratta, Maria Grazia, Strippoli, Antonia, Filippi, Roberto, Satolli, Maria Antonietta, Petrillo, Angelica, Daniele, Bruno, De Tursi, Michele, Di Marino, Pietro, Giordano, Guido, Landriscina, Matteo, Vitale, Pasquale, Zurlo, Ina Valeria, Dell’Aquila, Emanuela, Tomao, Silverio, Depetris, Ilaria, Di Pietro, Francesca Romana, Zoratto, Federica, Ciardiello, Davide, Pensieri, Maria Vittoria, Garrone, Ornella, Galassi, Barbara, Ferri, Claudio, Berardi, Rossana, Ghidini, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413268/
https://www.ncbi.nlm.nih.gov/pubmed/36033477
http://dx.doi.org/10.3389/fonc.2022.935826

Ejemplares similares

Ejemplares similares